Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2018/08/015287
CTRI/2018/08/015287
Not yet recruiting
Phase 2

Clinical assessment and evaluation of therapeutic management of maantha sanni(autism spectrum disorder) with maantha sanni thylam(Internal & External)

ATIONAL INSTITUTE OF SIDDHA0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- 1 Poor eye contact 2 Mild aggresive behavior 3 Repetative behavior 4 Lack of communication skills

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: null- 1 Poor eye contact 2 Mild aggresive behavior 3 Repetative behavior 4 Lack of communication skills
Sponsor
ATIONAL INSTITUTE OF SIDDHA
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Clinically diagnosed as Autism spectrum disorder (ASD)
  • •Poor eye contact
  • •Mild aggressive behaviour
  • •Repetative behaviour
  • •Lack of communication skills

Exclusion Criteria

  • •Severe aggressive behaviour
  • •Seizure with hyperactivity
  • •Cerebral palsy with hyperactivity
  • •Attention deficit hyperactivity disorder (ADHD)
  • •Congenital anomalies
  • •Any other serious illness

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 1
Role of sarvakalpa ghan vati in liver disease.Health Condition 1: K768- Other specified diseases of liver
CTRI/2020/06/025733Dr Zeba Malik
Completed
Phase 2
Ayurvedic Management Of Hepatitis BHealth Condition 1: K739- Chronic hepatitis, unspecified
CTRI/2018/05/014023Patanjali Ayurveda College50
Not yet recruiting
Not Applicable
To evaluate the efficacy of Sarvakalpa-ghan-vati in management of non-alcoholic liver disorder.Health Condition 1: K77- Liver disorders in diseases classified elsewhere
CTRI/2020/07/026362Patanjali Research Institute
Completed
Phase 3
Maha analuruva chooranam (internal) and Chennagarapattai ennai (external)for the management of Baalavatham(Paresis) in childreHealth Condition 1: G328- Other specified degenerative disorders of nervous system in diseases classified elsewhere
CTRI/2021/08/035549ational Institute of Siddha30
Completed
Phase 4
Evaluation of therapeutic efficacy and safety of artesunate-amodiaquine, artemether-lumefantrine and dihydroartemisinine-piperaquine for the treatment of uncomplicated Plasmodium falciparum in Democratic Republic of CongoMalariaInfection - Studies of infection and infectious agents
ACTRN12616001423404Ministry of Health534